These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 15056407)

  • 1. Omalizumab and the treatment of allergic rhinitis.
    Kaliner MA
    Curr Allergy Asthma Rep; 2004 May; 4(3):237-44. PubMed ID: 15056407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omalizumab: an effective anti-IgE treatment for allergic asthma and rhinitis.
    Casale TB;
    Drugs Today (Barc); 2004 Apr; 40(4):367-76. PubMed ID: 15190389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy.
    Holgate ST; Djukanović R; Casale T; Bousquet J
    Clin Exp Allergy; 2005 Apr; 35(4):408-16. PubMed ID: 15836747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omalizumab in asthma: approval and postapproval experience.
    Chiang DT; Clark J; Casale TB
    Clin Rev Allergy Immunol; 2005 Aug; 29(1):3-16. PubMed ID: 16222080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-IgE treatment: an update.
    Babu KS; Arshad SH; Holgate ST
    Allergy; 2001 Dec; 56(12):1121-8. PubMed ID: 11736740
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR.
    Vignola AM; Humbert M; Bousquet J; Boulet LP; Hedgecock S; Blogg M; Fox H; Surrey K
    Allergy; 2004 Jul; 59(7):709-17. PubMed ID: 15180757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of immunoglobulin E and immune inflammation: implications in allergic rhinitis.
    Poole JA; Rosenwasser LJ
    Curr Allergy Asthma Rep; 2005 May; 5(3):252-8. PubMed ID: 15842964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is new in antiimmunoglobulin E asthma therapy.
    Berger WE
    Allergy Asthma Proc; 2005; 26(6):428-34. PubMed ID: 16541964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Omalizumab, recombinant humanized monoclonal antibody anti-IgE -- new fields of studies on the therapeutic indications].
    Kupryś-Lipińska I; Kuna P
    Pneumonol Alergol Pol; 2009; 77(1):43-51. PubMed ID: 19308909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of omalizumab on symptoms of seasonal allergic rhinitis: a randomized controlled trial.
    Casale TB; Condemi J; LaForce C; Nayak A; Rowe M; Watrous M; McAlary M; Fowler-Taylor A; Racine A; Gupta N; Fick R; Della Cioppa G;
    JAMA; 2001 Dec; 286(23):2956-67. PubMed ID: 11743836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting immunoglobulin E as a novel treatment for asthma.
    Sandström T
    Curr Allergy Asthma Rep; 2005 Mar; 5(2):109-15. PubMed ID: 15683610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A recombinant humanized anti-IgE monoclonal antibody (omalizumab) in the therapy of moderate-to-severe allergic asthma.
    D'Amato G; Piccolo A; Salzillo A; Noschese P; D'Amato M; Liccardi G
    Recent Pat Inflamm Allergy Drug Discov; 2007 Nov; 1(3):225-31. PubMed ID: 19075985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. World Asthma and COPD Forum. Clinical trial results with omalizumab.
    D'Amato G
    IDrugs; 2008 Jul; 11(7):489-92. PubMed ID: 18600594
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-IgE therapy: clinical utility beyond asthma.
    Casale TB; Stokes J
    J Allergy Clin Immunol; 2009 Apr; 123(4):770-1.e1. PubMed ID: 19348915
    [No Abstract]   [Full Text] [Related]  

  • 15. Omalizumab: a monoclonal anti-IgE antibody.
    Belliveau PP
    MedGenMed; 2005 Jan; 7(1):27. PubMed ID: 16369332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omalizumab : other indications and unanswered questions.
    Mankad VS; Burks AW
    Clin Rev Allergy Immunol; 2005 Aug; 29(1):17-30. PubMed ID: 16222081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omalizumab for treatment of allergic rhinitis.
    Vashisht P; Casale T
    Expert Opin Biol Ther; 2013 Jun; 13(6):933-45. PubMed ID: 23621175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omalizumab.
    Easthope S; Jarvis B
    Drugs; 2001; 61(2):253-60; discussion 261. PubMed ID: 11270941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-IgE for the treatment of allergic rhinitis--and eventually nasal polyps?
    Verbruggen K; Van Cauwenberge P; Bachert C
    Int Arch Allergy Immunol; 2009; 148(2):87-98. PubMed ID: 18799888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of allergic rhinitis and other immunoglobulin E-mediated diseases with anti-immunoglobulin E antibody.
    Berger WE
    Allergy Asthma Proc; 2006; 27(2 Suppl 1):S29-32. PubMed ID: 16722329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.